37 studies found for:    " August 22, 2012":" September 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Cardiovascular Diseases;   HIV
Intervention:
22 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
23 Active, not recruiting Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
24 Active, not recruiting Increasing Availability and Acceptability of Circumcision in Zambia
Condition: HIV
Intervention: Behavioral: MC and sexual risk reduction
25 Completed Comparing the PrePex™ Device to Surgical MC for Rapid Scale Up of MC in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
26 Recruiting Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Condition: HIV
Interventions: Drug: Tenofovir;   Drug: Zidovudine
27 Completed Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Conditions: Circumcision Adult;   HIV CDC Category B2
Intervention: Device: PrePex™ device
28 Active, not recruiting Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
Condition: AIDS
Interventions: Biological: DNA vaccine;   Biological: DNA vaccine prime with the addition of electroporation;   Biological: rTV boost at week 16;   Biological: rTV boost at week 24;   Biological: rTV boost at week 32
29 Recruiting Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
30 Recruiting Rifampin and Nevirapine Interactions in Young Children
Conditions: Tuberculosis;   HIV
Intervention:
31 Recruiting A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc
32 Active, not recruiting A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
33 Recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
34 Active, not recruiting Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir
35 Not yet recruiting Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
36 Not yet recruiting Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
37 Recruiting Couple HIV Prevention for Drug Involved Male Offenders
Conditions: Sexually Transmitted Diseases;   Unsafe Sex;   Substance-Related Disorders
Interventions: Behavioral: Connect II;   Behavioral: TAU

Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page
Indicates status has not been verified in more than two years